SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-460097"
 

Search: onr:"swepub:oai:DiVA.org:uu-460097" > Antimicrobial Resis...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Colson, Abigail R.Univ Strathclyde, Strathclyde Business Sch, Management Sci, Glasgow, Lanark, Scotland. (author)

Antimicrobial Resistance : Is Health Technology Assessment Part of the Solution or Part of the Problem?

  • Article/chapterEnglish2021

Publisher, publication year, extent ...

  • Elsevier,2021
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-460097
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-460097URI
  • https://doi.org/10.1016/j.jval.2021.06.002DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Antimicrobial resistance is a serious challenge to the success and sustainability of our healthcare systems. There has been increasing policy attention given to antimicrobial resistance in the last few years, and increased amounts of funding have been channeled into funding for research and development of antimicrobial agents. Nevertheless, manufacturers doubt whether there will be a market for new antimicrobial technologies sufficient to enable them to recoup their investment. Health technology assessment (HTA) has a critical role in creating confidence that if valuable technologies can be developed they will be reimbursed at a level that captures their true value. We identify 3 deficiencies of current HTA processes for appraising antimicrobial agents: a methods-centric approach rather than problem-centric approach for dealing with new challenges, a lack of tools for thinking about changing patterns of infection, and the absence of an approach to epidemiological risks. We argue that, to play their role more effectively, HTA agencies need to broaden their methodological tool kit, design and communicate their analysis to a wider set of users, and incorporate long-term policy goals, such as containing resistance, as part of their evaluation criteria alongside immediate health gains.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Morton, AlecUniv Strathclyde, Strathclyde Business Sch, Management Sci, Glasgow, Lanark, Scotland. (author)
  • Årdal, ChristineNorwegian Inst Publ Hlth, Antimicrobial Resistance Ctr, Oslo, Norway. (author)
  • Chalkidou, KalipsoImperial Coll London, Sch Publ Hlth, London, England. (author)
  • Davies, Sally C.UK Dept Hlth & Social Care, London, England. (author)
  • Garrison, Louis P.Univ Washington, Comparat Hlth Outcomes Policy & Econ Inst, Seattle, WA 98195 USA. (author)
  • Jit, MarkLondon Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England. (author)
  • Laxminarayan, RamananCtr Dis Dynam Econ & Policy, Washington, DC USA. (author)
  • Megiddo, ItamarUniv Strathclyde, Strathclyde Business Sch, Management Sci, Glasgow, Lanark, Scotland. (author)
  • Morel, ChantalUppsala universitet,Företagsekonomiska institutionen,Univ Hosp Bonn, Inst Hyg & Publ Hlth, Bonn, Germany; Univ Geneva, Sci Fac, Geneva Transformat Governance Lab, Geneva, Switzerland(Swepub:uu)chamo685 (author)
  • Nonvignon, JusticeUniv Ghana, Sch Publ Hlth, Dept Hlth Policy Planning & Management, Legon, Ghana. (author)
  • Outterson, KevinBoston Univ, Sch Law, Boston, MA 02215 USA. (author)
  • Rex, John H.F2G Ltd, Eccles, Cheshire, England.;AMR Solut, Boston, MA USA. (author)
  • Sarker, Abdur RazzaqueBangladesh Inst Dev Studies, Dhaka, Bangladesh. (author)
  • Sculpher, MarkUniv York, Ctr Hlth Econ, York, N Yorkshire, England. (author)
  • Woods, BethUniv York, Ctr Hlth Econ, York, N Yorkshire, England. (author)
  • Xiao, YueNatl Ctr Med & Hlth Technol Assessment, China Natl Hlth Dev Res Ctr, Beijing, Peoples R China. (author)
  • Univ Strathclyde, Strathclyde Business Sch, Management Sci, Glasgow, Lanark, Scotland.Norwegian Inst Publ Hlth, Antimicrobial Resistance Ctr, Oslo, Norway. (creator_code:org_t)

Related titles

  • In:Value in Health: Elsevier24:12, s. 1828-18341098-30151524-4733

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view